Although some studies have provided evidence that COX-2 expression and NF-κB regulation are strongly associated with the benefits of aspirin intake in colorectal and breast cancers43,44, some epidemiological studies showed that improved breast cancer survival associated with aspirin use is independent of COX-2 or NF-κB30,45. Here, NFKB1 is linked to breast carcinoma.